ID:MYC_HUMAN DESCRIPTION: RecName: Full=Myc proto-oncogene protein; AltName: Full=Class E basic helix-loop-helix protein 39; Short=bHLHe39; AltName: Full=Proto-oncogene c-Myc; AltName: Full=Transcription factor p64; FUNCTION: Participates in the regulation of gene transcription. Binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Seems to activate the transcription of growth-related genes. SUBUNIT: Efficient DNA binding requires dimerization with another bHLH protein. Binds DNA as a heterodimer with MAX. Interacts with TAF1C and SPAG9. Interacts with PARP10. Interacts with KDM5A and KDM5B. Interacts (when phosphorylated at Thr-58 and Ser-62) with FBXW7. Interacts with PIM2 (By similarity). Interacts with NO66. INTERACTION: P03070:- (xeno); NbExp=2; IntAct=EBI-447544, EBI-617698; Q15059:BRD3; NbExp=3; IntAct=EBI-447544, EBI-1383460; P11802:CDK4; NbExp=2; IntAct=EBI-447544, EBI-295644; Q86XR8:CEP57; NbExp=3; IntAct=EBI-447544, EBI-308614; Q14839:CHD4; NbExp=2; IntAct=EBI-447544, EBI-372916; O15111:CHUK; NbExp=3; IntAct=EBI-447544, EBI-81249; Q15029:EFTUD2; NbExp=5; IntAct=EBI-447544, EBI-357897; Q969H0:FBXW7; NbExp=2; IntAct=EBI-447544, EBI-359574; Q8N3Y1:FBXW8; NbExp=3; IntAct=EBI-447544, EBI-914770; Q92769:HDAC2; NbExp=2; IntAct=EBI-447544, EBI-301821; Q8TCG1:KIAA1524; NbExp=2; IntAct=EBI-447544, EBI-1379376; Q8N163:KIAA1967; NbExp=8; IntAct=EBI-447544, EBI-355410; P61244:MAX; NbExp=21; IntAct=EBI-447544, EBI-751711; P52164:Max (xeno); NbExp=4; IntAct=EBI-447544, EBI-1184963; P33993:MCM7; NbExp=6; IntAct=EBI-447544, EBI-355924; O75928:PIAS2; NbExp=4; IntAct=EBI-447544, EBI-348555; Q96EB6:SIRT1; NbExp=4; IntAct=EBI-447544, EBI-1802965; Q13309:SKP2; NbExp=2; IntAct=EBI-447544, EBI-456291; Q8TAD8:SNIP1; NbExp=9; IntAct=EBI-447544, EBI-749336; P08047:SP1; NbExp=4; IntAct=EBI-447544, EBI-298336; P11387:TOP1; NbExp=2; IntAct=EBI-447544, EBI-876302; Q9Y4A5:TRRAP; NbExp=4; IntAct=EBI-447544, EBI-399128; P17480:UBTF; NbExp=2; IntAct=EBI-447544, EBI-396235; Q13105:ZBTB17; NbExp=2; IntAct=EBI-447544, EBI-372156; SUBCELLULAR LOCATION: Nucleus, nucleoplasm. Nucleus, nucleolus. PTM: Phosphorylated by PRKDC. Phosphorylation at Thr-58 and Ser-62 by GSK3 is required for ubiquitination and degradation by the proteasome. Phosphorylation at Ser-329 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-62 by CDK2 prevents Ras-induced senescence. PTM: Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-58 and Ser-62, leading to its degradation by the proteasome. In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation. In the nucleolus, however, ubiquitination is not counteracted by USP28, due to the lack of interaction between isoform 4 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus. Also polyubiquitinated by the DCX(TRUSS) complex. DISEASE: Note=Overexpression of MYC is implicated in the etiology of a variety of hematopoietic tumors. DISEASE: Note=A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1. DISEASE: Defects in MYC are a cause of Burkitt lymphoma (BL) [MIM:113970]. A form of undifferentiated malignant lymphoma commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. Note=Chromosomal aberrations involving MYC are usually found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or t(2;8) which juxtapose MYC to one of the heavy or light chain immunoglobulin gene loci. BIOTECHNOLOGY: POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 are the four Yamanaka factors. When combined, these factors are sufficient to reprogram differentiated cells to an embryonic-like state designated iPS (induced pluripotent stem) cells. iPS cells exhibit the morphology and growth properties of ES cells and express ES cell marker genes. SIMILARITY: Contains 1 bHLH (basic helix-loop-helix) domain. WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and Haematology; URL="http://atlasgeneticsoncology.org/Genes/MYCID27.html"; WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/myc/"; WEB RESOURCE: Name=Wikipedia; Note=Myc entry; URL="http://en.wikipedia.org/wiki/Myc";
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on P01106
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000978 RNA polymerase II core promoter proximal region sequence-specific DNA binding GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0001077 transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding GO:0003677 DNA binding GO:0003700 transcription factor activity, sequence-specific DNA binding GO:0005515 protein binding GO:0008134 transcription factor binding GO:0033613 activating transcription factor binding GO:0044877 macromolecular complex binding GO:0046983 protein dimerization activity GO:0070491 repressing transcription factor binding GO:0070888 E-box binding
Biological Process: GO:0000082 G1/S transition of mitotic cell cycle GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0000165 MAPK cascade GO:0001658 branching involved in ureteric bud morphogenesis GO:0002053 positive regulation of mesenchymal cell proliferation GO:0006112 energy reserve metabolic process GO:0006338 chromatin remodeling GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0006357 regulation of transcription from RNA polymerase II promoter GO:0006366 transcription from RNA polymerase II promoter GO:0006879 cellular iron ion homeostasis GO:0006974 cellular response to DNA damage stimulus GO:0007050 cell cycle arrest GO:0007219 Notch signaling pathway GO:0008284 positive regulation of cell proliferation GO:0010332 response to gamma radiation GO:0010468 regulation of gene expression GO:0010628 positive regulation of gene expression GO:0015671 oxygen transport GO:0016579 protein deubiquitination GO:0019221 cytokine-mediated signaling pathway GO:0032204 regulation of telomere maintenance GO:0032873 negative regulation of stress-activated MAPK cascade GO:0032986 protein-DNA complex disassembly GO:0034644 cellular response to UV GO:0035690 cellular response to drug GO:0042493 response to drug GO:0043066 negative regulation of apoptotic process GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0044346 fibroblast apoptotic process GO:0045656 negative regulation of monocyte differentiation GO:0045893 positive regulation of transcription, DNA-templated GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0048146 positive regulation of fibroblast proliferation GO:0048147 negative regulation of fibroblast proliferation GO:0050679 positive regulation of epithelial cell proliferation GO:0051276 chromosome organization GO:0051782 negative regulation of cell division GO:0051973 positive regulation of telomerase activity GO:0060070 canonical Wnt signaling pathway GO:0070371 ERK1 and ERK2 cascade GO:0070848 response to growth factor GO:0071456 cellular response to hypoxia GO:0090096 positive regulation of metanephric cap mesenchymal cell proliferation GO:1904837 beta-catenin-TCF complex assembly GO:2000573 positive regulation of DNA biosynthetic process GO:2001022 positive regulation of response to DNA damage stimulus